One of the Chief campaigners of the 21st Century Cures Act, Dr. Mark J. Holterman has promised to speak on the dividends of the act. In fact, his grandstand on this Act comes from his passion for research on cellular-based analysis and general pediatric studies. A look at the link between regenerative medicine and the act finds that the two are intertwined to show that well-executed research on diseases allows for medical preparedness. The preparedness, in this case, enables the state to plan for better medical services accorded to its people. Still, in achieving a viable medical services plan, the collaborative efforts between the federal government and Dr. Mark Holterman’s organization, the Mariam Global Health, will ensure a workable plan exists.
Passing of the Legislation into an Act
In 2016 Dr. Mark J. Holterman was a key consultant to the Congress sitting that discussed the act (Interview.net). In November, the US Congress had passed the 21st Century Cures Act, and President Obama signed it as an act. Through the legislation, the existence of a bi-partisan alliance in the same Congress helped patients with chronic health conditions to access new drugs and better medical facilities. It has realized that he had a significant amount of his time and efforts to engage partners such as Food and Drugs Association (FDA).
Even as the Act builds on the FDA’s incorporation of the inputs that addresses the drug approval requirements. In this regard, the organization gives provision for a quicker and an efficient approval process. Belonging to the groups such as the World Stem Cell Summit and Alliance for Regenerative Medicine (ARM) to ascertain the level of preparedness for the new legislation.
Who is Dr. Holterman?
Dr. Mark Holterman is a pediatric surgeon has garnered more than two decades of service and expertise in pediatric research. Since 2011, he has been the longest-serving member of the General Surgical Team at OSF Healthcare. In other capacities, Dr. Mark Holterman is also a distinguished professor at University of Illinois’s College of Medical Sciences where he lectures on Pediatric Surgery. Additionally, he is the CEO of Mariam Global Health, an organization that focusses on regenerative medicine through research on fast-tracking the development of better cell-based therapeutic initiatives.